2.24
price down icon0.44%   -0.010
after-market After Hours: 2.24
loading
Cyclerion Therapeutics Inc stock is traded at $2.24, with a volume of 26,723. It is down -0.44% in the last 24 hours and down -3.86% over the past month. Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$2.25
Open:
$2.3
24h Volume:
26,723
Relative Volume:
0.08
Market Cap:
$7.48M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-1.0467
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
-3.86%
1M Performance:
-3.86%
6M Performance:
-18.55%
1Y Performance:
-6.67%
1-Day Range:
Value
$2.2103
$2.3089
1-Week Range:
Value
$2.2103
$2.4599
52-Week Range:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Name
Cyclerion Therapeutics Inc
Name
Phone
617-621-7722
Name
Address
301 BINNEY STREET, CAMBRIDGE, MA
Name
Employee
1
Name
Twitter
@Cyclerion
Name
Next Earnings Date
2024-12-15
Name
Latest SEC Filings
Name
CYCN's Discussions on Twitter

Compare CYCN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
2.24 7.21M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-21 Initiated Truist Buy
Sep-24-21 Initiated Cantor Fitzgerald Overweight
Jun-03-19 Initiated Credit Suisse Neutral

Cyclerion Therapeutics Inc Stock (CYCN) Latest News

pulisher
11:57 AM

Will Cyclerion Therapeutics Inc. stock recover faster than peersWeekly Investment Summary & Reliable Entry Point Alerts - Trung tâm Dự báo KTTV quốc gia

11:57 AM
pulisher
12:11 PM

Published on: 2025-10-16 23:11:04 - newser.com

12:11 PM
pulisher
Oct 16, 2025

Pattern recognition hints at Cyclerion Therapeutics Inc. upside2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Using R and stats models for Cyclerion Therapeutics Inc. forecastingShare Buyback & Capital Protection Trading Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Tick level data insight on Cyclerion Therapeutics Inc. volatilityWeekly Investment Recap & Stock Timing and Entry Methods - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Detecting support and resistance levels for Cyclerion Therapeutics Inc.2025 Trade Ideas & High Win Rate Trade Tips - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Can momentum traders help lift Cyclerion Therapeutics Inc.July 2025 Retail & Verified Chart Pattern Trade Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Published on: 2025-10-15 03:45:24 - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 3% Higher – Here’s Why - Defense World

Oct 15, 2025
pulisher
Oct 14, 2025

Should you hold or exit Cyclerion Therapeutics Inc. now2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How to use a screener to detect Cyclerion Therapeutics Inc. breakoutsJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Cyclerion Therapeutics, Inc. (CYCN) Stock Price, News, Quote & History - Yahoo

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 10:09:21 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Why Cyclerion Therapeutics Inc. stock is recommended by analystsJuly 2025 Update & Fast Gain Swing Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to recover losses in Cyclerion Therapeutics Inc. stockTrade Ideas & Long Hold Capital Preservation Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Cyclerion Therapeutics Inc Stock Analysis and ForecastMarket Insider Reports & Build Balanced Portfolio - earlytimes.in

Oct 13, 2025
pulisher
Oct 10, 2025

Leading vs lagging indicators on Cyclerion Therapeutics Inc. performanceIndex Update & Free Community Supported Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 06:28:37 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Cyclerion Therapeutics Inc. stock ready for a breakoutJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:00:18 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What MACD signals say about Cyclerion Therapeutics Inc.July 2025 Decliners & Growth Oriented Trading Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Trend Bullish continuation from March 2025Sector-Based Investing & Rapid Portfolio Strategies - earlytimes.in

Oct 08, 2025
pulisher
Oct 06, 2025

Best data tools to analyze Cyclerion Therapeutics Inc. stockJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - newser.com

Oct 06, 2025
pulisher
Oct 03, 2025

Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Technicals & Verified Entry Point Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Cyclerion Therapeutics Inc. stock volume spike explainedTrade Signal Summary & Short-Term High Return Strategies - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Cyclerion Therapeutics Inc. price bounce be sustainableJobs Report & Short-Term Swing Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What drives Cyclerion Therapeutics Inc stock pricePortfolio Diversification Tips & Affordable Market Trading - earlytimes.in

Oct 02, 2025

Cyclerion Therapeutics Inc Stock (CYCN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Cap:     |  Volume (24h):